Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Ozanimod is approved by both the FDA and the EMA for the treatment of moderately to severely active ulcerative colitis (UC) in adults. The FDA approved ozanimod for this indication in May 2021, based on pivotal phase 3 trials, and it is also approved in the European Union as the first oral sphingosine-1-phosphate (S1P) receptor modulator for this indication (1, 2)
A Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitisis published by Sands et al.…